Dr. Matthew D. Sims, MD

Dr. Sims practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Sims' NPI, 1205851730, was assigned on July 13, 2006. Dr. Sims graduated from Rush Medical College of Rush University in 2012. Dr. Sims holds Michigan license 4301088222.

Dr. Sims' primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Sims' primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Sims is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Sims to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sims practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sims' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Sims' licenses on file in 2 states: Michigan and New York.

CMS data shows 238 Medicare services from Dr. Sims across 5 procedure codes in 2024, for 151 Medicare patients. Medicare paid $25,403 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Sims in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sims' median patient age at 62, with 54% women.

In 2024, Dr. Sims wrote 170 Medicare Part D claims for 49 patients. 80% of them were for generic drugs. CMS names the drug for 107 of them, across 4 drugs with 11 or more claims each, at $93,530 in total drug cost. In 2023, CMS named 65 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sims for performance year 2024, reported as part of a group. Dr. Sims accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sims as offering telehealth.

Dmand AI links 38 papers to Dr. Sims, published from 2010 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Anti-Bacterial Agents, Clostridioides difficile and Clostridium Infections. Dr. Sims has published most often in Clin Infect Dis. Dr. Sims' most frequent co-authors are Elaine Wang, MD, Vance G. Fowler, MD and Colleen Suzanne Kraft, MD.

Dmand AI links Dr. Sims to 6 clinical trials, 3 of them phase 2 studies. Conditions studied include Cytokine Release Syndrome, Severe Acute Respiratory Syndrome and Clostridium Infections. William Beaumont Hospitals sponsors the most, 4.

CMS Open Payments shows 17 general payments to Dr. Sims from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Merck Sharp & Dohme Corporation paid the most, $2,827.

Dr. Sims graduated from Rush Medical College of Rush University in 2012.